...
首页> 外文期刊>Pediatric blood & cancer >Adrenal axis function after high-dose steroid therapy for childhood acute lymphoblastic leukemia.
【24h】

Adrenal axis function after high-dose steroid therapy for childhood acute lymphoblastic leukemia.

机译:大剂量激素治疗儿童急性淋巴细胞白血病后的肾上腺轴功能。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: A 4-week course of high-dose glucocorticoids may cause prolonged adrenal suppression even after a 9-day tapering phase. In this study, adrenal function and signs and symptoms of adrenal insufficiency were prospectively assessed in children with acute lymphoblastic leukemia (ALL) after induction treatment including high-dose prednisone (PDN) or dexamethasone (DXM). PROCEDURES: Sixty-four children with ALL, treated according to the AIEOP ALL 2000 Study protocol, underwent low dose ACTH (LD-ACTH) stimulation 24 hr after the last tapered steroid dose. In those with impaired cortisol response, additional LD ACTH tests were performed every 1-2 weeks until cortisol levels normalized. Signs and symptoms of adrenal insufficiency were recorded during the observation period. RESULTS: All patients had normal basal cortisol values at diagnosis. Twenty-four hours after last glucocorticoid dose, morning cortisol was reduced in 40/64 (62.5%) patients. LD-ACTH testing showed adrenal suppression in 52/64 (81.5%) patients. At the following ACTH test 7-14 days later, morning cortisol values were reduced in 8/52 (15.4%) patients and response to the test was impaired in 12/52 (23%). Adrenal function completely recovered in all patients within 10 weeks. No difference was found between patients treated with PDN or DXM. Almost 35% of children with impaired cortisol values at the first test developed signs or symptoms of adrenal insufficiency. One child developed a severe adrenal crisis during adrenal suppression. CONCLUSIONS: High-dose glucocorticoid therapy in ALL children may cause prolonged adrenal suppression and related clinical symptoms. Laboratory monitoring of cortisol levels and steroid coverage during stress episodes may be indicated.
机译:背景:即使在9天逐渐缩小阶段后,大剂量糖皮质激素4周疗程也可能导致长时间的肾上腺抑制。在这项研究中,对包括高剂量泼尼松(PDN)或地塞米松(DXM)在内的诱导治疗后的急性淋巴细胞白血病(ALL)患儿的肾上腺功能以及肾上腺功能不全的症状和体征进行了前瞻性评估。程序:根据AIEOP ALL 2000研究方案治疗的64例ALL儿童,在最后一次锥形类固醇剂量后24小时接受低剂量ACTH(LD-ACTH)刺激。在皮质醇反应不良的患者中,每1-2周进行一次额外的LD ACTH测试,直至皮质醇水平恢复正常。在观察期间记录肾上腺功能不全的体征和症状。结果:所有患者在诊断时均具有正常的基础皮质醇值。最后一次糖皮质激素给药后二十四小时,40/64(62.5%)患者的早晨皮质醇减少。 LD-ACTH测试显示有52/64(81.5%)患者的肾上腺抑制。在7-14天后的下一次ACTH测试中,8/52(15.4%)患者的早晨皮质醇值降低,而12/52(23%)患者对测试的反应减弱。 10周内所有患者的肾上腺功能完全恢复。在接受PDN或DXM治疗的患者之间未发现差异。在初次测试中,皮质醇值受损的儿童中几乎有35%出现肾上腺功能不全的体征或症状。一个孩子在肾上腺抑制过程中发生了严重的肾上腺危机。结论:所有儿童大剂量糖皮质激素治疗可能导致长时间的肾上腺抑制和相关的临床症状。可能需要在压力发作期间实验室监测皮质醇水平和类固醇覆盖率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号